Literature DB >> 3578326

In vitro study with ciprofloxacin: interpretive criteria of agar diffusion test according to standards of the NCCLS and DIN.

H Grimm.   

Abstract

Regression analyses to determine the correlation between minimal inhibitory concentrations (MICs) and inhibition zones produced by ciprofloxacin disks were carried out using 400 freshly isolated cultures of infective organisms (approximately 20 strains from each of 22 species). It was found in pilot studies that the correlation becomes weaker with increasing disk loads (1, 5, 10, and 30 micrograms). Disks containing 5 micrograms of ciprofloxacin were chosen for comparative studies using Mueller-Hinton agar and methods of the National Committee for Clinical and Laboratory Standards (NCCLS) as well as of the Deutsches Institut für Normung (DIN 58940). Based on preliminary MIC breakpoints (susceptible, 1 microgram/ml or less; intermediate, 2 micrograms/ml; and resistant, 4 micrograms/ml or more) and calculations from regression equations (limited to the MIC range of 0.25 to 32 micrograms/ml), the following zone interpretations using the NCCLS method are recommended: resistant, 15 mm or less; intermediate, 16 to 20 mm; and susceptible, 21 mm or more. The respective values with the DIN method are resistant, 18 mm or less; intermediate, 19 to 22 mm; and susceptible, 23 mm or more.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3578326

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  5 in total

1.  Interpretive criteria of antimicrobial disk susceptibility tests with cefpodoxime.

Authors:  H Grimm
Journal:  Infection       Date:  1991 Sep-Oct       Impact factor: 3.553

2.  Interaction study of lomefloxacin and ciprofloxacin with omeprazole and comparative pharmacokinetics.

Authors:  H Stuht; H Lode; P Koeppe; K L Rost; T Schaberg
Journal:  Antimicrob Agents Chemother       Date:  1995-05       Impact factor: 5.191

Review 3.  Clinical pharmacokinetics of ciprofloxacin.

Authors:  K Vance-Bryan; D R Guay; J C Rotschafer
Journal:  Clin Pharmacokinet       Date:  1990-12       Impact factor: 6.447

Review 4.  Pharmacokinetics of quinolones: newer aspects.

Authors:  J S Wolfson; D C Hooper
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267

Review 5.  Fluoroquinolone antimicrobial agents.

Authors:  J S Wolfson; D C Hooper
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.